Sign up for the premium plan and unlock all options
After purchasing the premium plan, you will unlock all information about drug prices and their availability.
Search
Listing 182821 - 182840 out of 566319 entries
| Country | ATC | Drug name | Drug form, strength, package | Price level | Price in € | Price in local currency | Therapeutic areas | Manufacturer / Importer |
|---|---|---|---|---|---|---|---|---|
| Czech Republic | (L01DB03) epirubicin | EPIRUBICIN TEVA | 2MG/ML, 2MG/ML INJ SOL 1X25ML I , VIA | Retail price with vat |
$0-0 |
$0-0 |
n/a | TevaB.V.,Haarlem |
| Czech Republic | (L01DB03) epirubicin | EPIRUBICIN TEVA | 2MG/ML, 2MG/ML INJ SOL 1X25ML II , VIA | Retail price with vat |
$0-0 |
$0-0 |
n/a | TevaB.V.,Haarlem |
| Czech Republic | (L01EE05) mirdametinib | EZMEKLY | 1MG, 1MG CPS DUR 42 , TBC | Retail price with vat |
$0-0 |
$0-0 |
Neurofibromatosis 1;Neurofibroma, Plexiform | MerckEuropeB.V.,Amsterdam |
| Czech Republic | (L01EE05) mirdametinib | EZMEKLY | 2MG, 2MG CPS DUR 42 , TBC | Retail price with vat |
$0-0 |
$0-0 |
Neurofibromatosis 1;Neurofibroma, Plexiform | MerckEuropeB.V.,Amsterdam |
| Czech Republic | (L01EE05) mirdametinib | EZMEKLY | 2MG, 2MG CPS DUR 84 , TBC | Retail price with vat |
$0-0 |
$0-0 |
Neurofibromatosis 1;Neurofibroma, Plexiform | MerckEuropeB.V.,Amsterdam |
| Czech Republic | (L01EE05) mirdametinib | EZMEKLY | 1MG, 1MG TBL SUS 42 , TBC | Retail price with vat |
$0-0 |
$0-0 |
Neurofibromatosis 1;Neurofibroma, Plexiform | MerckEuropeB.V.,Amsterdam |
| Czech Republic | (L01EE05) mirdametinib | EZMEKLY | 1MG, 1MG TBL SUS 84 , TBC | Retail price with vat |
$0-0 |
$0-0 |
Neurofibromatosis 1;Neurofibroma, Plexiform | MerckEuropeB.V.,Amsterdam |
| Czech Republic | (L01EF02) ribociclib (adm: O) | KISQALI | 200MG, 200MG TBL FLM 42 I , BLI | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms | NovartisEuropharmLimited,Dublin |
| Czech Republic | (L01EF02) ribociclib (adm: O) | KISQALI | 200MG, 200MG TBL FLM 42 II , BLI | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms | NovartisEuropharmLimited,Dublin |
| Czech Republic | (L01EG02) everolimus (adm: O) | EVEROLIMUS TEVA | 2,5MG, 2,5MG TBL NOB 30X1 , BLJ | Retail price with vat |
$0-0 |
$0-0 |
n/a | TevaPharmaceuticalsCR,s.r.o.,Praha |
| Czech Republic | (L01EG02) everolimus (adm: O) | EVEROLIMUS TEVA | 5MG, 5MG TBL NOB 30X1 , BLJ | Retail price with vat |
$0-0 |
$0-0 |
n/a | TevaPharmaceuticalsCR,s.r.o.,Praha |
| Czech Republic | (L01EX03) pazopanib (adm: O) | PAZOPANIB SANDOZ | 400MG, 400MG TBL FLM 60 , BLI | Retail price with vat |
$0-0 |
$0-0 |
n/a | Sandozs.r.o.,Praha |
| Czech Republic | (L01EX03) pazopanib (adm: O) | PAZOPANIB SANDOZ | 200MG, 200MG TBL FLM 30 , BLI | Retail price with vat |
$0-0 |
$0-0 |
n/a | Sandozs.r.o.,Praha |
| Czech Republic | (L01EX08) lenvatinib (adm: O) | LENVATINIB SANDOZ | 10MG, 10MG CPS DUR 30 I , BLI | Retail price with vat |
$0-0 |
$0-0 |
n/a | Sandozs.r.o.,Praha |
| Czech Republic | (L01EX08) lenvatinib (adm: O) | LENVATINIB SANDOZ | 4MG, 4MG CPS DUR 30 I , BLI | Retail price with vat |
$0-0 |
$0-0 |
n/a | Sandozs.r.o.,Praha |
| Czech Republic | (L01FC02) isatuximab | SARCLISA | 20MG/ML, 20MG/ML INF CNC SOL 1X25ML , VIA | Retail price with vat |
$0-0 |
$0-0 |
Multiple Myeloma | SanofiWinthropIndustrie,Gentilly |
| Czech Republic | (L01FC02) isatuximab | SARCLISA | 20MG/ML, 20MG/ML INF CNC SOL 1X5ML , VIA | Retail price with vat |
$0-0 |
$0-0 |
Multiple Myeloma | SanofiWinthropIndustrie,Gentilly |
| Czech Republic | (L01FD01) trastuzumab (adm: P) | TRAZIMERA | 150MG, 150MG INF PLV CSL 1 , VIA | Retail price with vat |
$0-0 |
$0-0 |
Stomach Neoplasms;Breast Neoplasms | PfizerEuropeMAEEIG,Bruxelles |
| Czech Republic | (L01FD01) trastuzumab (adm: P) | ZERCEPAC | 150MG, 150MG INF PLV CSL 1 , VIA | Retail price with vat |
$0-0 |
$0-0 |
Breast Neoplasms;Stomach Neoplasms | AccordHealthcareS.L.U.,Barcelona |
| Czech Republic | (L02BG06) exemestane (adm: O) | AROMASIN | 25MG, 25MG TBL FLM 90 , BLI | Retail price with vat |
$0-0 |
$0-0 |
n/a | Pfizer,spol.sr.o.,Praha |
Pages
